Autonomous Therapeutics, Inc.
PrivateLast Round
Grant
Dec 20, 2024
Total Funding Raised
$55.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autonomous Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Grant round in December 2024.
Autonomous Therapeutics, Inc. is a biotechnology company that develops precision nucleic acid-based therapeutics for the treatment of infectious diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autonomous Therapeutics, Inc. Comparables
Compare Autonomous Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bristol Myers Squibb | 78% | |
| Radar Therapeutics | 78% | |
| aceRNA Technologies Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Autonomous Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2024 | ||||
| Grant | Aug 24, 2023 | ||||
| Grant | May 7, 2021 | ||||
| Grant | Feb 21, 2020 | ||||
| Grant | Nov 8, 2019 | ||||
Grant | Dec 28, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Autonomous Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Department of the Interior | Grant |
| Naval Air Warfare Center | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Defense Advanced Research Projects Agency | Grant |
| National Institutes of Health (NIH) | Grant |
| Johnson & Johnson Innovation - JLABS | Grant |
| Third Kind Venture Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 125% MoM, reaching 7.7K.
- Apr 17, 2026
Monthly visitors grew 280% MoM to 13.6K.
For institutional investors. Book with your work email.
Autonomous Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Autonomous Therapeutics, Inc.'s valuation, stock price, and market status.
Is Autonomous Therapeutics, Inc. a public or private company?
Autonomous Therapeutics, Inc. is a private company.
What is the current stock price of Autonomous Therapeutics, Inc.?
Autonomous Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Autonomous Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Autonomous Therapeutics, Inc. worth (valuation)?
Valuation information for Autonomous Therapeutics, Inc. is not publicly available.
Can I buy Autonomous Therapeutics, Inc. stock?
Autonomous Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Autonomous Therapeutics, Inc.'s last funding round?
Autonomous Therapeutics, Inc.'s most recent funding round was Grant on December 20, 2024.
Who are the main investors in Autonomous Therapeutics, Inc.?
Key investors in Autonomous Therapeutics, Inc. include Department of the Interior, Naval Air Warfare Center, Defense Advanced Research Projects Agency, National Institutes of Health (NIH).
Will Autonomous Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Autonomous Therapeutics, Inc..
How can I track Autonomous Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Autonomous Therapeutics, Inc.'s shares on secondary markets.